Condition

Advanced Solid Neoplasms (4)

Lymphoma Neoplasms (1)

Lymphoma, Malignant (1)

Overall Status

Withdrawn (2)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

phase 2 (1)

Sponsor

Millennium Pharmaceuticals, Inc. (2)

Janssen Research & Development, LLC (1)

Merck Sharp & Dohme LLC (1)

Collaborator

AstraZeneca (1)

Intervention

tak-659 (2)

[14c]-tak-659 (1)

jnj-64457107 (1)

olaparib (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

advanced solid neoplasms

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Solid Tumors Trial in Worldwide (Olaparib)

Recruiting

Advanced Solid Neoplasms

Olaparib

Tucson, Arizona
+128 more

Aug 18, 2022

Advanced Solid Tumors Trial in Israel, Spain (JNJ-64457107)

Completed

Advanced Solid Neoplasms

JNJ-64457107

Haifa, Israel
+3 more

Oct 21, 2021

Advanced Solid Tumors, Lymphoma Tumors Trial ([14C]-TAK-659, TAK-659)

Withdrawn

Advanced Solid Neoplasms
Lymphoma Neoplasms

(no location specified)

Mar 26, 2018

Lymphoma, Malignant, Advanced Solid Tumors Trial in New Haven, Detroit, Bronx (TAK-659)

Withdrawn

Lymphoma, Malignant
Advanced Solid Neoplasms

TAK-659

New Haven, Connecticut
+2 more

Mar 26, 2018